Moreover, immunofluorescent staining showed that the infiltrating Gr-1+-MDSC was significantly decreased in tumor from FFAR2 inhibitor or combination therapy group (Additional file 1: Fig. S9A–C). Here, FFAR2 is linked to neoplasm.